| 產(chǎn)品名稱 | GSK 2126458 - Omipalisib |
| 產(chǎn)品貨號 | Axon 1596 CAS [1086062-66-9] MF C25H17F2N5O3SMW 505.50 Purity: 99% Soluble in DMSO Description Highly potent and orally bioavailable inhibitor of PI3K and mTOR in vitro and in vivo; Ki values to be 0.019, 0.13, 0.024 and 0.06 nM for p110 α, β, δ and γ isoforms and 0.18 and 0.3 nM for mTORC1 and mTORC2 respectively. KEYWORDS:?GSK 2126458 | supplier |?PI3K/mTOR inhibitor | Omipalisib | GSK2126458 | GSK-2126458 | CAS [1086062-66-9] | Phosphatidylinositol | mTOR | PI3K | orally bioavailable | TORC |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
GSK 2126458 - OmipalisibAxon 1596 CAS [1086062-66-9] MF C25H17F2N5O3S
DescriptionHighly potent and orally bioavailable inhibitor of PI3K and mTOR in vitro and in vivo; Ki values to be 0.019, 0.13, 0.024 and 0.06 nM for p110 α, β, δ and γ isoforms and 0.18 and 0.3 nM for mTORC1 and mTORC2 respectively. KEYWORDS:?GSK 2126458 | supplier |?PI3K/mTOR inhibitor | Omipalisib | GSK2126458 | GSK-2126458 | CAS [1086062-66-9] | Phosphatidylinositol | mTOR | PI3K | orally bioavailable | TORC
Dual PI3K and mTOR inhibitor
Chemical name2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide Parent CAS No.[1086062-66-9] |
| 產(chǎn)品資料 |
